Saphenous vein graft disease: review of pathophysiology, prevention, and treatment

FY Kim, G Marhefka, NJ Ruggiero, S Adams… - Cardiology in …, 2013 - journals.lww.com
Saphenous vein graft (SVG) disease after coronary artery bypass grafting (CABG) occurs in
three phases: thrombosis, intimal hyperplasia, and atherosclerosis. Within the first month …

'No-touch'saphenous vein harvesting improves graft performance in patients undergoing coronary artery bypass surgery: a journey from bedside to bench

MR Dashwood, JC Tsui - Vascular Pharmacology, 2013 - Elsevier
The saphenous vein is the most commonly used conduit in patients undergoing coronary
artery bypass surgery yet its patency is inferior to the internal thoracic artery. Vascular …

The vasa vasorum and associated endothelial nitric oxide synthase is more important for saphenous vein than arterial bypass grafts

M Dreifaldt, D Souza, L Bodin, X Shi-Wen… - …, 2013 - journals.sagepub.com
No-touch (NT) saphenous vein (SV) grafts are superior to SVs harvested by the conventional
technique (CT), with a patency comparable with the internal thoracic artery (ITA) …

Fifteen Years of 'No-Touch'Saphenous Vein Harvesting in Patients Undergoing Coronary Artery Bypass Surgery: What Have We Learned?

MR Dashwood, DSR Souza - Inflammatory Response in Cardiovascular …, 2013 - Springer
Coronary artery disease (CAD) is the major cause of mortality in the Western world. Methods
for restoring blood supply to the heart have changed over the years and include …

[引用][C] 大隐静脉旁路血管周围存在脂肪源性脂联素及潜在临床意义

刘小龙, 李德闽, 王常田, 黄海嵘, 吴海卫, 申翼, 易俊… - 中华胸心血管外科杂志, 2013

[引用][C] Graft Patency on Symptom Directed Cardiac Catheterization and Leg Complications in Patients with “No-Touch” versus Endoscopically Harvested Saphenous …

JD Mannion, MD Daniel Marelli